Prospective Longitudinal Cohort Study of Vasculitis Patients

ConditionVasculitis

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorAssistance Publique - Hôpitaux de Paris

About this trial

VASCO is a prospective observational cohort study which aim to describe the presentation, comorbidities, management, outcomes and damage of vasculitis patients, from the analysis of the clinical, biological and immunological data.

Eligibility criteria

Qualifiers

Adult patients (age over 18 years),

Patients with vasculitis, as defined in the Chapel Hill International Nomenclature as revised in 2012,

Patients included at an active phase of the disease, either the initial flare or a relapse,

Patients who have been informed and have signed the consent

Disqualifiers

Refusal of consent or inability to obtain consent,

A patient who is insane or not entitled, for psychiatric reasons or intellectual impairment, to receive information about the protocol and to give informed consent,

Patient under guardianship / curators

Patient on state medical assistance (AME)

Trial design

Treatments tested in this trial

Data collection
Biological samples and data collection

Treatment groups

670 Participants

are divided into 2 treatment groups

Sponsors and collaborators

Assistance Publique - Hôpitaux de Paris

Lead sponsor

URC-CIC Paris Descartes Necker Cochin

Collaborator

Source ClinicalTrials.gov